The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Payment of early termination fee on operating lease termination settlement | - | - | 0 | - |
| Accounts receivable-Related Party | - | - | 88 | -88 |
| Other liabilities | - | - | 83 | -83 |
| Inventories | - | - | - | 551 |
| Refunds due to customers | - | - | -929 | 1,194 |
| Net cash used in operating activities attributable to discontinued operations | 0 | - | - | - |
| Depreciation and amortization | - | - | 16 | 96 |
| Net cash provided by investing activities attributable to discontinued operations | 0 | - | - | - |
| Loss on allowance for credit loss | - | 439 | 0 | -439 |
| Net cash provided by financing activities attributable to discontinued operations | 0 | - | - | - |
| Loss on issuance of warrants | - | 0 | - | - |
| Total cash used in discontinued operations | 0 | - | - | - |
| Impairment of goodwill from purchase of semicab,inc | - | 0 | - | - |
| Change in fair value of warrant liability | 0 | 0 | 0 | 6,468 |
| Net loss from continuing operations | -5,380 | -4,497 | -10,713 | - |
| Net foreign currency translation adjustment | 9 | 31 | - | - |
| Impairment expense | - | - | - | 0 |
| Depreciation and amortization of property and equipment and intangible assets | 93 | 249 | - | - |
| Reserve for sales returns | - | - | - | 2,834 |
| Amortization of debt discount and issuance cost | 762 | 212 | - | - |
| Credit losses | - | - | - | 3 |
| Reduction in smcb loan in exchange for services | - | 0 | 0 | -304 |
| Net loss | - | - | - | -10,103 |
| Stock-based compensation | 923 | 381 | 6 | 47 |
| Provision for inventory obsolescence | - | - | - | 4 |
| Accounts receivable-Nonrelated Party | - | - | 3,748 | -2,372 |
| Accounts receivable | -143 | 621 | - | - |
| Prepaid expenses and other current assets | 1,044 | -130 | -299 | 722 |
| Other non-current assets | 2 | 388 | 86 | -523 |
| Accounts payable | -429 | 109 | 2,729 | -2,184 |
| Accrued expenses | 420 | -161 | 1,571 | -1,147 |
| Other current liabilities | 619 | 69 | - | - |
| Provision for employee benefits | -18 | 144 | - | - |
| Provision for estimated cost of returns | - | - | - | -1,528 |
| Net cash used in operating activities attributable to continuing operations | -3,922 | -2,966 | -4,343 | - |
| Repurchase of shares of common stock | - | 0 | 0 | 758 |
| Due from banks | - | - | - | 0 |
| Pre-acquistion advances to semicab, inc | - | 0 | - | - |
| Cash received from acquisition of smcb | - | 0 | 0 | 593 |
| Net cash used in operating activities | - | - | - | -5,436 |
| Cash received from acquisition of semicab, inc. assets | - | 0 | 0 | - |
| Advances to smcb | 0 | 0 | 0 | 1,172 |
| Purchase of property and equipment | 14 | 4 | -12 | 22 |
| Capitalization of internal use software costs | 114 | -122 | 541 | - |
| Net cash used in investing activities attributable to continuing operations | -128 | 118 | -1,888 | - |
| Proceeds from sale of common stock and warrants, net of offering costs | - | 0 | 0 | - |
| Proceeds from issuance of senior secured notes, net of discounts | - | 0 | - | - |
| Payment of senior secured notes and debt issuance costs | - | 0 | - | - |
| Net cash used in investing activities | - | - | - | -1,359 |
| Payments on merchant cash advances payable | - | 0 | 0 | - |
| Other | - | 0 | 0 | 0 |
| Proceeds from issuance of promissory notes, net of offering costs and discounts | 9,020 | 10,213 | - | - |
| Proceeds from issuance of promissory notes, net | - | - | 3,914 | 379 |
| Payment of promissory notes | 177 | 249 | 178 | - |
| Payment of promissory notes, related parties | - | 100 | - | - |
| Net cash provided by financing activities attributable to continuing operations | 8,843 | 5,571 | 4,115 | - |
| Net change in cash | 4,793 | - | - | - |
| Net cash used in operating activities attributable to discontinued operations | 0 | 584 | -3,123 | - |
| Net cash provided by investing activities attributable to discontinued operations | 0 | 0 | 845 | - |
| Net cash provided by financing activities attributable to discontinued operations | 0 | 0 | 0 | - |
| Net cash provided by (used in) financing activities | - | - | - | 379 |
| Total cash used in discontinued operations | 0 | 584 | -2,278 | - |
| Net change in cash | 4,793 | 3,307 | 2,022 | -6,416 |
| Cash and cash equivalents at beginning of period | - | - | 7,233 | - |
| Cash and restricted cash at beginning of period | 2,839 | - | - | - |
| Cash and cash equivalents at end of period | - | - | 2,839 | - |
| Cash and restricted cash at end of period | 10,939 | - | - | - |
Algorhythm Holdings, Inc. (RIME)
Algorhythm Holdings, Inc. (RIME)